Idioma:

Vancomycin-resistant enterococcus in pediatric oncology patients: An analysis of potential consequences of colonization and infection

Kosack, Amanda ; Riedel, Elyn ; Kiehn, Timothy E. ; Small, Trudy N. ; Wexler, Leonard H. ; Dunkel, Ira J.

Pediatric Blood & Cancer, 2009-02, Vol.52 (2), p.300-302 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por

Enviar para

Título:
Vancomycin-resistant enterococcus in pediatric oncology patients: An analysis of potential consequences of colonization and infection
Autor: Kosack, Amanda ; Riedel, Elyn ; Kiehn, Timothy E. ; Small, Trudy N. ; Wexler, Leonard H. ; Dunkel, Ira J.
Assuntos: Adolescent ; Adult ; Child ; Child, Preschool ; colonization ; Enterococcus ; Female ; Humans ; Incidence ; Infant ; infection ; Male ; mucositis ; Neoplasms - complications ; neutropenia ; Retrospective Studies ; Streptococcal Infections - etiology ; Vancomycin Resistance ; vancomycin-resistant enterococcus ; Young Adult
É parte de: Pediatric Blood & Cancer, 2009-02, Vol.52 (2), p.300-302
Notas: istex:524941A80E39428FD7093B637498BAE29F19CC85
ArticleID:PBC21793
The Fund for Ophthalmic Knowledge
ark:/67375/WNG-K0GGQCVC-W
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: A retrospective analysis of 57 pediatric oncology patients with a baseline positive vancomycin‐resistant enterococcus (VRE) culture who subsequently received chemotherapy and/or radiation therapy was performed. The incidence of subsequent VRE infection was calculated using a competing risk analysis accounting for death from non‐VRE causes as a competing risk. Ten patients had subsequent VRE infection. The cumulative incidence of subsequent infection was 14% (7–27%, 95% confidence interval) at 1 year and 16% (9–29%, 95% confidence interval) at 2 years. None of the hypothesized risk factors appeared to differ between patients who developed a subsequent infection and those who did not. Pediatr Blood Cancer 2009;52:300–302. © 2008 Wiley‐Liss, Inc.
Editor: Hoboken: Wiley Subscription Services, Inc., A Wiley Company
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Vancomycin-resistant enterococcus in pediatric oncology patients: An analysis of potential consequences of colonization and infection

Kosack, Amanda ; Riedel, Elyn ; Kiehn, Timothy E. ; Small, Trudy N. ; Wexler, Leonard H. ; Dunkel, Ira J.

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Buscando em bases de dados remotas. Favor aguardar.